RedHill Biopharma (RDHL) Interest Expenses (2012 - 2025)
RedHill Biopharma (RDHL) posted quarterly Interest Expenses of $1.9 million for Q2 2023, down 54.3% year-over-year from $4.2 million in Q2 2022, and up 357.48% quarter-over-quarter from $421000.0 in Q1 2023.
RedHill Biopharma (RDHL) Interest Expenses (2012 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has reported Interest Expenses for 12 consecutive years, with $1.9 million the latest figure, recorded in Q2 2023.
- In Q2 2023, Interest Expenses fell 54.3% year-over-year to $1.9 million; the TTM figure through Dec 2024 stood at $1.9 million (down 60.11% YoY), while the FY2025 annual figure was $1.5 million, down 3.7% from the prior year.
- Interest Expenses improved to $1.9 million in Q2 2023 per RDHL's latest filing, from $421000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $31.8 million in Q3 2022 and bottomed at -$206000.0 in Q3 2019.
- Historically, Interest Expenses has averaged $4.3 million across 5 years, with a median of $3.1 million in 2020.
- Annual changes were most pronounced in 2019 — Interest Expenses tumbled 142.92% — and 2020, when it surged 4767.91%.
- RedHill Biopharma's Interest Expenses stood at $187000.0 in 2019, then soared by 4767.91% to $9.1 million in 2020, then tumbled by 92.96% to $641000.0 in 2021, then jumped by 287.05% to $2.5 million in 2022, then slipped by 22.37% to $1.9 million in 2023.
- Business Quant data shows RDHL's Interest Expenses at $1.9 million in Q2 2023, $421000.0 in Q1 2023, and $2.5 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.09 Bn |
| Jun 30, 2025 | 1.09 Bn |
| Dec 31, 2024 | 1.51 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Jun 30, 2023 | 1.93 Mn |
| Jun 30, 2023 | 1.93 Mn |
| Mar 31, 2023 | 421,000.00 |
| Mar 31, 2023 | 421,000.00 |
| Dec 31, 2022 | 2.48 Mn |
| Dec 31, 2022 | 2.48 Mn |
| Sep 30, 2022 | 31.78 Mn |
| Sep 30, 2022 | 31.78 Mn |
| Jun 30, 2022 | 4.21 Mn |
| Jun 30, 2022 | 4.21 Mn |
| Mar 31, 2022 | 3.91 Mn |
| Mar 31, 2022 | 3.91 Mn |
| Dec 31, 2021 | 641,000.00 |
| Dec 31, 2021 | 641,000.00 |
| Sep 30, 2021 | 4.01 Mn |
| Sep 30, 2021 | 4.01 Mn |